Kepos Capital LP - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 43 filers reported holding REDHILL BIOPHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2019$656,000
-13.7%
108,0000.0%0.06%
-17.3%
Q3 2019$760,000
+8.3%
108,0000.0%0.08%
+5.6%
Q2 2019$702,000
-21.7%
108,0000.0%0.07%
+6.0%
Q1 2019$897,000
+34.7%
108,000
-10.0%
0.07%
+31.4%
Q4 2018$666,000
-65.5%
120,000
-45.2%
0.05%
-48.5%
Q3 2018$1,932,000
+3.5%
218,8000.0%0.10%
+4.2%
Q2 2018$1,866,000218,8000.10%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2018
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 367,346$926,0000.15%
DISCIPLINED GROWTH INVESTORS INC /MN 1,950,002$4,914,0000.11%
Claret Asset Management Corp 95,430$240,0000.05%
Annandale Capital, LLC 43,532$110,0000.04%
ARK Investment Management 861,798$2,172,0000.01%
Virtu Financial LLC 26,864$68,0000.01%
Ancora Advisors LLC 82,048$207,0000.01%
OSAIC HOLDINGS, INC. 4,600$1,372,0000.00%
TWO SIGMA SECURITIES, LLC 25,499$64,0000.00%
ATTICUS WEALTH MANAGEMENT, LLC 2,425$6,0000.00%
View complete list of REDHILL BIOPHARMA LTD shareholders